4//SEC Filing
Cutler Adam D. 4
Accession 0000950170-25-033761
CIK 0001971543other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:47 PM ET
Size
7.6 KB
Accession
0000950170-25-033761
Insider Transaction Report
Form 4
Cutler Adam D.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2025-03-03+35,000→ 106,438 total - Award
Stock Option (right to buy)
2025-03-03+65,000→ 65,000 totalExercise: $3.43Exp: 2035-03-02→ Ordinary Shares (65,000 underlying)
Footnotes (3)
- [F1]Consists of ordinary shares issuable under 35,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of March 1, 2025, subject to the reporting person's continued service with the Issuer.
- [F2]Includes 59,144 unvested restricted stock units.
- [F3]This option was granted on March 3, 2025. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on March 1, 2026 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued services with the Issuer.
Documents
Issuer
Mural Oncology plc
CIK 0001971543
Entity typeother
Related Parties
1- filerCIK 0001722673
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:47 PM ET
- Size
- 7.6 KB